We are live on ! Find out more
Millennium Management

Millennium Management Portfolio holdings

AUM $240B
1-Year Est. Return 35.51%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Fund
S&P 500
This Quarter Est. Return
+11.46%
1 Year Est. Return
+35.51%
3 Year Est. Return
+105.02%
5 Year Est. Return
+129.21%
10 Year Est. Return
+672.54%
AUM
$79.9B
AUM Growth
+$16.7B
Cap. Flow
+$9.74B
Cap. Flow %
12.19%
Top 10 Hldgs %
13.34%
Holding
4,935
New
829
Increased
1,631
Reduced
1,587
Closed
796

Sector Composition

Rank Sector Weight
1 Healthcare 9.65%
2 Technology 8.5%
3 Financials 8.48%
4 Consumer Discretionary 7.65%
5 Industrials 7.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NBEV
4051
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$60K ﹤0.01%
32,745
-33,873
-51% -$80.2K
ISUN
4052
DELISTED
iSun, Inc. Common Stock
ISUN
$59K ﹤0.01%
23,891
-8,270
-26% -$25.1K
SREV
4053
DELISTED
ServiceSource International, Inc.
SREV
$57K ﹤0.01%
33,944
-19,850
-37% -$25.9K
VSTM icon
4054
Verastem
VSTM
$539M
$56K ﹤0.01%
3,502
-1,032
-23% -$14.8K
ECOR icon
4055
electroCore
ECOR
$50.7M
$55K ﹤0.01%
+2,321
New +$59.1K
INO icon
4056
Inovio Pharmaceuticals
INO
$79.5M
$55K ﹤0.01%
+1,396
New +$42K
OESX icon
4057
Orion Energy Systems
OESX
$43M
$55K ﹤0.01%
1,640
-8,158
-83% -$245K
TOUR
4058
Tuniu
TOUR
$55.9M
$55K ﹤0.01%
+2,178
New +$61.2K
AVXL icon
4059
Anavex Life Sciences
AVXL
$234M
$54K ﹤0.01%
+20,994
New +$55.1K
NL icon
4060
NLI Holdings
NL
$281M
$53K ﹤0.01%
13,600
-3,130
-19% -$12.8K
SIOX
4061
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$53K ﹤0.01%
10,310
+72
+0.7% +$399
MBII
4062
DELISTED
Marrone Bio Innovations, Inc.
MBII
$52K ﹤0.01%
51,743
-132,806
-72% -$161K
FBRX icon
4063
Forte Biosciences
FBRX
$1.57B
$51K ﹤0.01%
257
+163
+173% +$36.9K
EGIO
4064
DELISTED
Edgio, Inc. Common Stock
EGIO
$51K ﹤0.01%
+312
New +$49.4K
ARDS
4065
DELISTED
Aridis Pharmaceuticals Inc. Common Stock
ARDS
$51K ﹤0.01%
11,446
-14,123
-55% -$74.5K
ELVT
4066
DELISTED
Elevate Credit, Inc.
ELVT
$50K ﹤0.01%
11,210
-7,273
-39% -$30.4K
RRD
4067
DELISTED
RR Donnelley & Sons Co.
RRD
$49K ﹤0.01%
12,383
-29,321
-70% -$116K
MBIO icon
4068
Mustang Bio
MBIO
$4.72M
$48K ﹤0.01%
16
-23
-59% -$52.7K
PANL icon
4069
Pangaea Logistics
PANL
$488M
$48K ﹤0.01%
16,305
-4,905
-23% -$15.3K
WEI
4070
DELISTED
Weidai Ltd. American depositary shares, each representing five (5) Class A ordinary shares
WEI
$45K ﹤0.01%
2,865
-5,029
-64% -$129K
GRWG icon
4071
GrowGeneration
GRWG
$88.3M
$44K ﹤0.01%
+10,715
New +$45.5K
AFI
4072
DELISTED
Armstrong Flooring, Inc.
AFI
$44K ﹤0.01%
10,399
-123,452
-92% -$604K
NEOS
4073
DELISTED
Neos Therapeutics, Inc
NEOS
$44K ﹤0.01%
28,919
-11,761
-29% -$17.6K
GEG icon
4074
Great Elm Group
GEG
$67.7M
$43K ﹤0.01%
12,930
-3,099
-19% -$10.3K
ACOR
4075
DELISTED
Acorda Therapeutics
ACOR
$43K ﹤0.01%
175
-204
-54% -$51.5K

Similar funds

Millennium Management's Q4 2019 Portfolio in Review

As of Q4 2019, Millennium Management held 4,935 positions worth $79.9B, up 26% from $63.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Millennium Management deployed $9.74B of net new capital in Q4 2019, opening 829 new positions and adding to 1,631 existing holdings. Its largest new stake was International Flavors & Fragrances: 535,214 shares worth $69.1M.

By sector, the portfolio is most concentrated in Healthcare at 9.7% of assets, down from 11% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Lowe's Companies, an estimated $326M trimmed.

  • Millennium Management's largest Q4 2019 buy was International Flavors & Fragrances: 535,214 shares worth $69.1M.
  • Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $3.83B increase.
  • Millennium Management's biggest Q4 2019 reduction was Lowe's Companies, cutting an estimated $326M.
  • Millennium Management fully exited Celgene Corp in Q4 2019, selling an estimated $414M.
  • Millennium Management's ten largest holdings make up 13% of its $79.9B portfolio in Q4 2019.
  • Millennium Management opened 829 new positions and closed 796 in Q4 2019.
  • Millennium Management's portfolio value rose 26% quarter-over-quarter to $79.9B.

Based on Millennium Management's 13F filing for Q4 2019, filed 14 Feb 2020.